HPE Discover 2025 – HPE (NYSE: HPE) today announced a single, unified partner program consolidating existing programs to enhance partner experiences across the entire HPE portfolio. All programs ...

Word count: 2,270 TWST: We’ve spoken before, but just for readers who may not be familiar, let’s start with a refresher on the company, its mission, and some milestones. Mr. Do: BioVie has two ...

In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...

In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...

Sanofi has developed a simpler way to create site-specific antibody-to-mannose-6-phosphate (M6P) conjugates that eliminates the need for enzyme remodeling. This more straightforward method makes ...

See the latest McPhy Energy SA stock price (M6P:XMUN), related news, valuation, dividends and more to help you make your investing decisions.

Reenie Perkovic, Registered Psychotherapist (Qualifying), Toronto, ON, M6P, (416) 966-5123, I’m Reenie (she/they) and I’m a queer therapist who values the importance of lived experiences and ...

Jesse Lawther, Registered Psychotherapist (Qualifying), Toronto, ON, M6P, (437) 747-0903, I work with queer people who are in the midst of change; grieving what once was, what could have been, and ...

In five poster presentations, including two Contemporary Forum presentations, M6P Therapeutics’ researchers report preclinical efficacy results for LSDs, including Gaucher disease and Pompe disease.

Patients with early-onset lysosomal storage diseases are ideal candidates for prenatal therapy because organ damage starts in utero. We report the safety and efficacy results of in utero enzyme-rep ...

M6P Therapeutics announced a poster presentation at the 29th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) 2022.

GCase uptake and distribution in the CNS was also evaluated by immunohistochemical staining About M6P Therapeutics M6P Therapeutics is a privately held, venture-backed biotechnology company developing ...